Podcast 14 Feb 2025Reversing cancer mechanisms to fight back against solid tumors This week, we have a conversation with Catalym’s Eugen Leo about Visugromab is a monoclonal antibody that neutralizes the tumor-derived growth differentiation factor-15. February 14, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 7 Feb 2025Targeting the dark genome to develop new therapies to fight obesity This week, our podcast guest is Samir Ounzain, CEO of Haya Therapeutics. Ounzain was one of the first researchers to publish on lncRNA, also known as the ‘dark genome.’ February 7, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 31 Jan 2025Can tumor activated therapy kill solid tumors? Solid tumors are a big challenge. However, a new approach might provide the answer – tumor-activated Therapy. We discuss this with Seekyo Therapeutics’ CEO, Oury Chetboun January 31, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 24 Jan 2025J.P. Morgan Annual Healthcare Conference 2025: trends and highlights you may have missed With Orca Bio’s CEO, Ivan Dimov,, we take a look at some of the highlights from the 43rd Annual J.P. Morgan Healthcare Conference January 24, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 17 Jan 2025Venture capital co-creation: The next big thing in biotech investment? This week, we talked with Jessica Owen, co-founder of Initiate Ventures, a venture firm with an interesting dual model. January 17, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 10 Jan 2025Fighting pain with non-opioid drugs In the first episode of 2025, we talk about non-opioid pain drugs with Brixton Biosciences. January 10, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 27 Dec 2024[Rebroadcast] The power of natural killer cells December 27, 2024 Share WhatsApp Twitter Linkedin Email Listen Now More
Podcast 20 Dec 2024Looking at 2025 biotech trends with SoftBank Vision Fund In our discussion with John Cassidy from SoftBank Vision Fund, we cover investment trends within life sciences, the European health and biotech scene December 20, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 13 Dec 2024Finding new treatments for peanut allergy Individuals with peanut allergies are at constant risk of severe reactions, and this week, we talk about new treatments with Jessica Grossman of IgGenix. December 13, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 6 Dec 2024Cracking the code of biotech valuations Our guest on the podcast this week to discuss the biotech scene in Eastern Europe, and look at some of the challenges facing biotech companies is Adam Marťák, CEO of ambiom. December 6, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 29 Nov 2024Can biotech beat mosquito-borne diseases? With mosquito-borne diseases on the rise, Oxitec’s Friendly mosquitoes are designed to suppress populations of disease-spreading mosquitoes. November 29, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 22 Nov 2024Could antigen modulation address autoimmune diseases? To tell us more about antigen modulation this week is Pete Joyce, CEO and co-founder of Grey Wolf Therapeutics. November 22, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More